|
N
|
NEOPHARMED GENTILI UK LIMITED ActiveMarketing And Merchandising Services |
Contact information
Unlock Company Insights Free Access
Get instant access to key company data, decision-maker contacts, and verified insights.
Book a Demo nowFinancial statements of NEOPHARMED GENTILI UK LIMITED
According to NEOPHARMED GENTILI UK LIMITED latest financial report submitted on 2025-12-31, the company has a Turnover of £7M, Gross-Profit of £663,890.00 while the Cash is £253,596.00. Compared with the previous year, the company reported a Turnover increase of 71.52%, which is an equivalent of -4808704. At the same time, the Gross-Profit went up by 73.78%, or by -489817.
NEOPHARMED GENTILI UK LIMITED Business Credit Report
A Business Credit Report for NEOPHARMED GENTILI UK LIMITED is available for instant download. The report will provide you with a credit score and credit limit recommendation for NEOPHARMED GENTILI UK LIMITED, payment trends, if the company pays their Invoices on time, whether or not the company has any court judgements, ownership and group structure, up to 5 years of financial statements and much more. When you buy a Credit Report from Global Database, you will also have a 7 days free trial to our B2B Sales Platform.
NEOPHARMED GENTILI UK LIMITED
NEOPHARMED GENTILI UK LIMITED Directors and key executives
NEOPHARMED GENTILI UK LIMITED currently employs 12 people. Compared with the previous year, the company has reported a staff increase of 50%, which is an equivalent of 4 employees. In order to view contact information, including emails and phone numbers for all the employees working at NEOPHARMED GENTILI UK LIMITED and to export them in XL or to your existing CRM, you can subscribe to our platform here.
Total Employee Count
Total employees
12
150%
1y growth
100%
2y growth
Management Level
Middle
| Employee | Job Title | Phone | Country | |
|---|---|---|---|---|
| Kevin Greaney | Director |
-
|
- | GB |
| Luke Robinson | Director |
-
|
- | GB |
| George Stanley | Medical Director |
-
|
- | GB |
Get direct emails & phone numbers for senior executives working at «NEOPHARMED GENTILI UK LIMITED»
Download our chrome extension and enrich prospect profiles in seconds. Organize contacts into focus lists, send e-mails or embed leads into automated sequences straight off their Linkedin profile - without leaving the browser.
Install Free Browser ExtensionNEOPHARMED GENTILI UK LIMITED Ownership and Group Structure
Explore the Full Corporate Tree.
Uncover parent companies, subsidiaries, and global linkages
Book a DemoNEOPHARMED GENTILI UK LIMITED competitors:
Top 5 similar companies of NEOPHARMED GENTILI UK LIMITED are COSMARIDA LIMITED, BIO-TECH SOLUTIONS LIMITED, NEW NORDIC LIMITED, ENZYME COMMUNICATIONS LTD, PRINCIPLE HEALTHCARE LIMITED. View and export all the competitor list of NEOPHARMED GENTILI UK LIMITED by upgrading your account here.
COSMARIDA LIMITED
BIO-TECH SOLUTIONS LIMITED
NEW NORDIC LIMITED
ENZYME COMMUNICATIONS LTD
PRINCIPLE HEALTHCARE LIMITED
View & Export NEOPHARMED GENTILI UK LIMITED competitors:
Get the complete list with detailed profiles
Book a DemoNEOPHARMED GENTILI UK LIMITED news & activities:
Turnover
NEOPHARMED GENTILI UK LIMITED has submitted new account statements and has reported a turnover of £7M, a 71.52% decrease year-over-year.
uk.globaldatabase.com
2025-12-31
EBITDA
The NEOPHARMED GENTILI UK LIMITED-based company said the adjusted EBITDA is now £688,445.00, compared with the previous year of 1.2 million.
uk.globaldatabase.com
2025-12-31
Employees
NEOPHARMED GENTILI UK LIMITED number of employees has increased by 50% compared with previous year and now represents a total number of 12.
uk.globaldatabase.com
2025-12-31
Frequently Asked Questions regarding NEOPHARMED GENTILI UK LIMITED
Where is NEOPHARMED GENTILI UK LIMITED registered office?
NEOPHARMED GENTILI UK LIMITED is located at 5 New Street Square, United Kingdom.
How many people work at NEOPHARMED GENTILI UK LIMITED?
According to the latest account statement, there are currently 12 of employees working for NEOPHARMED GENTILI UK LIMITED.
How much revenue does NEOPHARMED GENTILI UK LIMITED make?
Based on the latest financial accounts submitted on 2025-12-31, the company made £7M for 2025, which went up by 71.52%.
What is NEOPHARMED GENTILI UK LIMITED EBITDA?
For 2025, NEOPHARMED GENTILI UK LIMITED has reported an EBITDA of £688,445.00, which went up by 74.48% compared to previous year.
What is the Business Credit Score of NEOPHARMED GENTILI UK LIMITED and how reliable is the company?
In order to check the business credit score of NEOPHARMED GENTILI UK LIMITED, you can request a credit report. You will view the latest credit limit information, ownership, group structure, court judgements and much more.
Does NEOPHARMED GENTILI UK LIMITED pay their invoices on time?
By requesting a Business Credit Report for NEOPHARMED GENTILI UK LIMITED, you will be able to gain more insights about the NEOPHARMED GENTILI UK LIMITED payment trends.
Who is the Ultimate Parent of the NEOPHARMED GENTILI UK LIMITED?
Information about the ultimate beneficial ownership BIOCRYST PHARMAC************** of NEOPHARMED GENTILI UK LIMITED is available when you order a business credit report.
Access 100% verified registry data via API—company profiles, group structures, UBOs, financials, and more.
Get Free API AccessSearch for International Credit Report
|
Name
|
City
|
Address
|
Reg. No
|
Status
|
Action |
|---|
